BRUSSELS, July 10 Belgian medical supplies group
Arseus will sell its IT unit Corilus to fully
concentrate on medical compounds, Belgian business unit De Tijd
wrote on Thursday.
The group has made a string of divestments in recent
quarters and has focused spending on its medical compounding
unit Fagron, which supplies materials to pharmacies to make
While the revenues of Corilus, which makes software for
doctors and pharmacists, was still growing in the first quarter
of 2014, Fagron grew at more than twice the pace, even corrected
The process of selling Corilus was still at an early stage
and could take months, De Tijd wrote.
Arseus was not immediately available for comment.
(Reporting by Robert-Jan Bartunek)